| __timestamp | Celldex Therapeutics, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 6620800000 |
| Thursday, January 1, 2015 | 33837000 | 6533000000 |
| Friday, January 1, 2016 | 35979000 | 6452000000 |
| Sunday, January 1, 2017 | 25003000 | 6588100000 |
| Monday, January 1, 2018 | 19269000 | 5975100000 |
| Tuesday, January 1, 2019 | 15426000 | 6213800000 |
| Wednesday, January 1, 2020 | 14456000 | 6121200000 |
| Friday, January 1, 2021 | 20488000 | 6431600000 |
| Saturday, January 1, 2022 | 27195000 | 6440400000 |
| Sunday, January 1, 2023 | 30914000 | 6941200000 |
| Monday, January 1, 2024 | 8593800000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, managing costs is crucial. This chart highlights the Selling, General, and Administrative (SG&A) expenses of Eli Lilly and Company compared to Celldex Therapeutics, Inc. from 2014 to 2023. Eli Lilly, a giant in the industry, consistently reported SG&A expenses that were over 200 times higher than those of Celldex, reflecting its expansive operations and market reach. Notably, Eli Lilly's expenses peaked in 2023, showing a 16% increase from its lowest point in 2018. In contrast, Celldex's expenses fluctuated more dramatically, with a notable 114% increase from 2016 to 2023. This disparity underscores the different scales and strategies of these companies. As Eli Lilly continues to expand, Celldex's leaner operations may offer agility in a rapidly evolving market.
Eli Lilly and Company vs Intra-Cellular Therapies, Inc.: SG&A Expense Trends
Eli Lilly and Company or Insmed Incorporated: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Eli Lilly and Company or Viatris Inc.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Sarepta Therapeutics, Inc.
Breaking Down SG&A Expenses: Eli Lilly and Company vs CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and ACADIA Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Celldex Therapeutics, Inc.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Johnson & Johnson or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Walgreens Boots Alliance, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Perrigo Company plc vs Celldex Therapeutics, Inc. Trends and Insights